Dietary factors and fibroblast growth factor-23 levels in young adults with African ancestry

Journal of Bone and Mineral Metabolism

Volumn 35, Issue 6, 2017, Pages 666-674

  Kosk, Dominique ^a   Kramer, Holly ^a   Luke, Amy ^a   Camacho, Pauline ^b   Bovet, Pascal ^c,d   Rhule, Jacob Plange ^e   Forrester, Terrence ^f   Wolf, Myles ^g   Sempos, Chris ^h   Melamed, Michal L ⁱ   Dugas, Lara R ^a   Cooper, Richard ^a   Durazo Arvizu, Ramon ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

^d Ministry of Health   (Australia)

^e KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

^f UNIVERSITY OF THE WEST INDIES   (Jamaica)

^g NORTHWESTERN UNIVERSITY   (United States)

^h NATIONAL INSTITUTES OF HEALTH   (United States)

ⁱ ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Calcium intake; FGF23; Fibroblast growth factor 23; Phosphate intake; Vitamin D

Indexed keywords

FIBROBLAST GROWTH FACTOR 23; FIBROBLAST GROWTH FACTOR; PHOSPHATE;

ADULT; AFRICAN; ARTICLE; CALCIUM INTAKE; CALORIC INTAKE; CARBOXY TERMINAL SEQUENCE; CROSS-SECTIONAL STUDY; DIETARY INTAKE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; GHANA; HUMAN; MAGNESIUM INTAKE; MAJOR CLINICAL STUDY; MALE; OSTEOCYTE; PHOSPHATE BLOOD LEVEL; PHOSPHATE INTAKE; POPULATION; PREVALENCE; PRIORITY JOURNAL; SEYCHELLES; TROPIC CLIMATE; UNITED STATES; ANIMAL; BLACK PERSON; BLOOD; DIET; METABOLISM; MIDDLE AGED; YOUNG ADULT;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ANIMALS; CALCIUM, DIETARY; CROSS-SECTIONAL STUDIES; DIET; FEMALE; FIBROBLAST GROWTH FACTORS; HUMANS; MALE; MIDDLE AGED; PHOSPHATES; YOUNG ADULT;

EID: 85004098367     PISSN: 09148779     EISSN: 14355604     Source Type: Journal    
DOI: 10.1007/s00774-016-0804-5     Document Type: Article

References (40)

1. Ferrari SL, Bonjour JP, Rizzoli R (2005) Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men. J Clin Endocrinol Metab 90:1519–1524
2. Antoniucci DM, Yamashita T, Portale AA (2006) Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men. J Clin Endocrinol Metab 91:3144–3149
3. Burnett SM, Gunawardene SC, Bringhurst FR, Juppner H, Lee H, Finkelstein JS (2006) Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women. J Bone Miner Res 21:1187–1196
4. Tatsumi S, Miyagawa A, Kaneko I, Shiozaki Y, Segawa H, Miyamoto K (2016) Regulation of renal phosphate handling: inter-organ communication in health and disease. J Bone Miner Metab 34:1–10
5. Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, Takeuchi Y, Fujita T, Nakahara K, Fukomoto S, Yamashita T (2003) FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Min Res 19:429
6. Yuen SN, Kramer H, Luke A, Bovet P, Plange-Rhule J, Forrester T, Wolf M, Camacho P, Harders R, Dugas L, Cooper R, Durazo-Arvizu R (2016) Fibroblast growth factor (FGF-23) levels differ across populations by degree of industrialization. J Clin Endocrinol Metab 101:2246–2253
7. Eckberg K, Kramer H, Wolf M, Durazo-Arvizu R, Tayo B, Luke A, Cooper R (2015) Impact of westernization on fibroblast growth factor 23 levels among individuals of African ancestry. Nephrol Dial Transplant 30:630–635
8. Torre M, Rodriguez AR, Saura-Calixto F (1991) Effects of dietary fiber and phytic acid on mineral availability. Crit Rev Food Sci Nutr 30:1–22
9. di Giuseppe R, Kuhn T, Hirche F, Buijsse B, Dierkes J, Fritsche A, Kaaks R, Boeing H, Stangl GI, Weikert C (2015) Potential predictors of plasma fibroblast growth factor 23 concentrations: cross-sectional analysis in the EPIC-Germany Study. PLoS One 10:e0133580 (Electronic Resource)
10. Baia LC, Van den Berg E, Vervloet MG, Heilberg IP, Navis G, Bakker SJ, Geleijnse JM, Kromhout D, Soedamah-Muthu SS, De Borst MH, NIGRAM consortium (2014) Fish and omega-3 fatty acid intake in relation to circulating fibroblast growth factor 23 levels in renal transplant recipients. Nutr Metab Cardiovasc Dis 24:1310–1316
11. Vervloet MG, van Ittersum FJ, Buttler RM, Heijboer AC, Blankenstein MA, ter Wee PM (2011) Effects of dietary phosphate and calcium intake on fibroblast growth factor-23. Clin J Am Soc Nephrol 6:383–389
12. Cooper R, Forrester T, Ogunbiyi O, Muffinda J (1998) Angiotensinogen levels and obesity in four black populations. ICSHIB Investigators. J Hypertens 16:571–575
13. Luke A, Bovet P, Forrester TE, Lambert EV, Plange-Rhule J, Schoeller DA, Dugas LR, Durazo-Arvizu RA, Shoham D, Cooper RS, Brage S, Ekelund U, Steyn NP (2011) Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk. BMC Public Health 11:927
14. Steyn NP, Nel JH, Parker WA, Ayah R, Mbithe D (2011) Dietary, social, and environmental determinants of obesity in Kenyan women. Scand J Public Health 39:88–97
15. Orcholski L, Luke A, Plange-Rhule J, Bovet P, Forrester TE, Lambert EV, Dugas LR, Kettmann E, Durazo-Arvizu RA, Cooper RS, Schoeller DA (2015) Under-reporting of dietary energy intake in five populations of the African diaspora. Br J Nutr 113:464–472
16. Willett WC, Howe GR, Kushi LH (1997) Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 65:1220S–1228S
17. Curhan GC, Willet WC, Knight EL, Stampfer MJ (2004) Dietary factors and the risk of incident kidney stones in younger women. Arch Intern Med 164:885–891
18. Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, Kusek JW, Manzi J, Van Lente F, Zhang YL, Coresh J, Levey AS, CKD-EPI I (2012) Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 367:20–29
19. Tukey J (1957) On the comparative anatomy of transformations. Ann Math Sci 28:602–632
20. Walling MW (1977) Intestinal Ca and phosphate transport: differential responses to vitamin D3 metabolites. Am J Physiol 233:E488–E494
21. Braithwaite V, Jarjou LM, Goldberg GR, Prentice A (2012) Iron status and fibroblast growth factor-23 in Gambian children. Bone (NY) 50:1351–1356
22. Sullivan CM, Leon JB, Sehgal AR (2007) Phosphorus-containing food additives and the accuracy of nutrient databases: implications for renal patients. J Renal Nutr 17:350–354
23. Scialla JJ, Appel LJ, Wolf M, Yang W, Zhang X, Sozio SM, Miller ER 3rd, Bazzano LA, Cuevas M, Glenn MJ, Lustigova E, Kallem RR, Porter AC, Townsend RR, Weir MR, Anderson CA (2012) Chronic Renal Insufficiency Cohort-CRIC Study Group (2012) Plant protein intake is associated with fibroblast growth factor 23 and serum bicarbonate levels in patients with chronic kidney disease: the Chronic Renal Insufficiency Cohort study. J Renal Nutr 22:379–388.e1
24. Moe SM, Zidehsarai MP, Chambers MA, Jackman LA, Radcliffe JS, Trevino LL, Donahue SE, Asplin JR (2011) Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease. Clin J Am Soc Nephrol 6:257–264
25. Moorthi RN, Armstrong CL, Janda K, Ponsler-Sipes K, Asplin JR, Moe SM (2014) The effect of a diet containing 70% protein from plants on mineral metabolism and musculoskeletal health in chronic kidney disease. Am J Nephrol 40:582–591
26. Kim DJ, Holowaty EJ (2003) Brief, validated survey instruments for the measurement of fruit and vegetable intakes in adults: a review. Prev Med 36:440–447
27. Iqbal TH, Lewis KO, Cooper BT (1994) Phytase activity in the human and rat small intestine. Gut 35:1233–1236
28. Kalantar-Zadeh K, Gutekunst L, Mehrotra R, Kovesdy CP, Bross R, Shinaberger CS, Noori N, Hirschberg R, Benner D, Nissenson AR, Kopple JD (2010) Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease. Clin J Am Soc Nephrol 5:519–530
29. Kobayashi K, Imanishi Y, Miyauchi A, Onoda N, Kawata T, Tahara H, Goto H, Miki T, Ishimura E, Sugimoto T, Ishikawa T, Inaba M, Nishizawa Y (2006) Regulation of plasma fibroblast growth factor 23 by calcium in primary hyperparathyroidism. Eur J Endocrinol 154:93–99
30. Wesseling-Perry K, Wang H, Elashoff R, Gales B, Juppner H, Salusky IB (2014) Lack of FGF23 response to acute changes in serum calcium and PTH in humans. J Clin Endocrinol Metab 99:E1951–E1956
31. Isakova T, Ix JH, Sprague SM, Raphael KL, Fried L, Gassman JJ, Raj D, Cheung AK, Kusek JW, Flessner MF, Wolf M, Block GA (2015) Rationale and Approaches to phosphate and fibroblast growth factor 23 reduction in CKD. J Am Soc Nephrol 26:2328–2339
32. Block GA, Wheeler DC, Persky MS, Kestenbaum B, Ketteler M, Spiegel DM, Allison MA, Asplin J, Smits G, Hoofnagle AN, Kooienga L, Thadhani R, Mannstadt M, Wolf M, Chertow GM (2012) Effects of phosphate binders in moderate CKD. J Am Soc Nephrol 23:1407–1415
33. Khouzam NM, Wesseling-Perry K, Salusky IB (2015) The role of bone in CKD-mediated mineral and vascular disease. Pediatr Nephrol 30:1379–1388
34. Rodriguez-Ortiz ME, Lopez I, Munoz-Castaneda JR, Martinez-Moreno JM, Ramirez AP, Pineda C, Canalejo A, Jaeger P, Aguilera-Tejero E, Rodriguez M, Felsenfeld A, Almaden Y (2012) Calcium deficiency reduces circulating levels of FGF23. J Am Soc Nephrol 23:1190–1197
35. Spiegel DM (2007) The role of magnesium binders in chronic kidney disease. Semin Dial 20:333–336
36. Covic A, Passlick-Deetjen J, Kroczak M, Buschges-Seraphin B, Ghenu A, Ponce P, Marzell B, de Francisco AL (2013) A comparison of calcium acetate/magnesium carbonate and sevelamer-hydrochloride effects on fibroblast growth factor-23 and bone markers: post hoc evaluation from a controlled, randomized study. Nephrol Dial Transpl 28:2383–2392
37. de Francisco AL, Leidig M, Covic AC, Ketteler M, Benedyk-Lorens E, Mircescu GM, Scholz C, Ponce P, Passlick-Deetjen J (2010) Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerability. Nephrol Dial Transplant 25:3707–3717
38. David V, Martin A, Isakova T, Spaulding C, Qi L, Ramirez V, Zumbrennen-Bullough KB, Sun CC, Lin HY, Babitt JL, Wolf M (2016) Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production. Kidney Int 89:135–146
39. Wolf M, Koch TA, Bregman DB (2013) Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women. J Bone Miner Res 28:1793–1803
40. Wolf M (2010) Forging forward with 10 burning questions on FGF23 in kidney disease. J Am Soc Nephrol 21:1427–1435